Technology | July 12, 2010

New Beverage Improves Taste of Iodinated Contrast

July 12, 2010 – A new beverage has been released that masks the taste of oral iodinated contrast used in abdominal study CT scans. Breeza, by Beekley Corp., was developed in response to industry requests for a beverage to deliver oral iodinated contrast that patients would find more palatable, enabling them to drink the entire volume within the allotted time.

“Breeza has provided a contrast delivery product that almost every patient has tolerated well and not gagged getting down. This provides for a much more complete study and our patients appreciate having something that tastes good,” said CT scan technologist Joseph Piadade of Halifax Regional Hospital in South Boston, Va. “Patients are able to drink according to our instructions and the colon is well contrasted during the scan. We have noticed a marked decrease in intolerance and patients have no problem drinking the required amount for the study being performed.”

Breeza is sugar-free and tropical-fruit-flavored, and is sold premixed and packaged in 16 oz under-filled bottles, to allow for addition of the oral iodinated contrast. Using Breeza is also meant to save time, since facilities will not have to mix powdered drinks, coax patients to drink, employ nasogastric tubes or need to rescan.

For more information: www.beekley.com

Related Content

Study Finds No Evidence that Gadolinium Causes Neurologic Harm

MR images through, A, C, E, basal ganglia and, B, D, F, posterior fossa at level of dentate nucleus. Images are shown for, A, B, control group patient 4, and the, C, D, first and, E, F, last examinations performed in contrast group patient 13. Regions of interest used in quantification of signal intensity are shown as dashed lines for globus pallidus (green), thalamus (blue), dentate nucleus (yellow), and pons (red).

News | Contrast Media | January 11, 2018
January 11, 2018 — There is no evidence that accumulation in the brain of the element gadolinium speeds cognitive dec
CT Shows Enlarged Aortas in Former Pro Football Players

3-D rendering from a cardiac CT dataset demonstrating mild dilation of the ascending aorta.

News | Computed Tomography (CT) | January 11, 2018
Former National Football League (NFL) players are more likely to have enlarged aortas, a condition that may put them at...
Male Triathletes May Be Putting Their Heart Health at Risk
News | Cardiac Imaging | January 09, 2018
Competitive male triathletes face a higher risk of a potentially harmful heart condition called myocardial fibrosis,...
Toshiba Medical Systems Changes Name to Canon Medical Systems Corp.
News | Business | January 08, 2018
Canon Inc. and Canon Medical Systems Corp. announced the official corporate name (trade name) change of Canon Group...
New International Report Provides Comprehensive Guide to Imaging in Chagas Heart Disease
News | Cardiovascular Ultrasound | January 03, 2018
Chagas disease (ChD), an infectious parasitic disease transmitted primarily by triatomine insects, has become a...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
BlueCross BlueShield Companies in Eight States Issue Positive Medical Policies for HeartFlow FFRct Analysis
News | CT Angiography (CTA) | December 28, 2017
HeartFlow Inc. announced that Health Care Service Corp. (HCSC), which operates Blue Cross and Blue Shield plans in five...
Videos | Magnetic Resonance Imaging (MRI) | December 19, 2017
Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of Pitt
The FDA issued new warnings on MRI gadolinium contrast agents. (GBCAs)

The FDA issued new warnings on MRI gadolinium contrast agents. 

Feature | Magnetic Resonance Imaging (MRI) | December 19, 2017
The U.S.
Overlay Init